<VariationArchive RecordType="classified" VariationID="1685637" VariationName="NM_001287.6(CLCN7):c.2066del (p.Lys689fs)" VariationType="Deletion" Accession="VCV001685637" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-12-25" DateCreated="2022-05-28" MostRecentSubmission="2022-05-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1677652" VariationID="1685637">
      <GeneList>
        <Gene Symbol="CLCN7" FullName="chloride voltage-gated channel 7" GeneID="1186" HGNC_ID="HGNC:2025" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>16p13.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="1444935" stop="1475028" display_start="1444935" display_stop="1475028" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="1494933" stop="1525084" display_start="1494933" display_stop="1525084" Strand="-" />
          </Location>
          <OMIM>602727</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001287.6(CLCN7):c.2066del (p.Lys689fs)</Name>
      <CanonicalSPDI>NC_000016.10:1447661:TTT:TT</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>16p13.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="1447662" stop="1447662" display_start="1447662" display_stop="1447662" variantLength="1" positionVCF="1447661" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="1497663" stop="1497663" display_start="1497663" display_stop="1497663" variantLength="1" positionVCF="1497662" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>K665fs</ProteinChange>
      <ProteinChange>K689fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.1447664del" Assembly="GRCh38">
            <Expression>NC_000016.10:g.1447664del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.1497665del" Assembly="GRCh37">
            <Expression>NC_000016.9:g.1497665del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007567.1" sequenceAccession="NG_007567" sequenceVersion="1" change="g.32423del">
            <Expression>NG_007567.1:g.32423del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001114331.3" sequenceAccession="NM_001114331" sequenceVersion="3" change="c.1994del">
            <Expression>NM_001114331.3:c.1994del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001107803.1" sequenceAccession="NP_001107803" sequenceVersion="1" change="p.Lys665fs">
            <Expression>NP_001107803.1:p.Lys665fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001287.6" sequenceAccession="NM_001287" sequenceVersion="6" change="c.2066del" MANESelect="true">
            <Expression>NM_001287.6:c.2066del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001278.1" sequenceAccession="NP_001278" sequenceVersion="1" change="p.Lys689fs">
            <Expression>NP_001278.1:p.Lys689fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2142366092" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001287.6(CLCN7):c.2066del (p.Lys689fs) AND Autosomal dominant osteopetrosis 2" Accession="RCV002249364" Version="1">
        <ClassifiedConditionList TraitSetID="1895">
          <ClassifiedCondition DB="MedGen" ID="C3179239">Autosomal dominant osteopetrosis 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-05-04" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-05-04" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-05-28" MostRecentSubmission="2022-05-28">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="1895" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3686" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Autosomal dominant osteopetrosis 2</ElementValue>
                <XRef ID="MONDO:0008156" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ALBERS-SCHONBERG DISEASE, AUTOSOMAL DOMINANT</ElementValue>
                <XRef Type="MIM" ID="166600" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MARBLE BONES, AUTOSOMAL DOMINANT</ElementValue>
                <XRef Type="MIM" ID="166600" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">OSTEOSCLEROSIS FRAGILIS GENERALISATA</ElementValue>
                <XRef Type="MIM" ID="166600" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteopetroses</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Marble bones</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Albers-Schonberg disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteosclerosis fragilis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Albers-Schönberg osteopetrosis</ElementValue>
                <XRef ID="53" DB="Orphanet" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Albers-Schoenberg disease</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">OPTA2</ElementValue>
                <XRef Type="MIM" ID="166600" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="383" />
                <XRef ID="383" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The spectrum of CLCN7-related osteopetrosis includes infantile malignant CLCN7-related autosomal recessive osteopetrosis (ARO), intermediate autosomal osteopetrosis (IAO), and autosomal dominant osteopetrosis type II (ADOII; Albers-Schönberg disease). ARO. Onset is at birth. Findings may include: fractures; reduced growth; sclerosis of the skull base (with or without choanal stenosis or hydrocephalus) resulting in optic nerve compression, facial palsy, and hearing loss; absence of the bone marrow cavity resulting in severe anemia and thrombocytopenia; dental abnormalities, odontomas, and risk for mandibular osteomyelitis; and hypocalcemia with tetanic seizures and secondary hyperparathyroidism. Without treatment maximal life span in ARO is ten years. IAO. Onset is in childhood. Findings may include: fractures after minor trauma, characteristic skeletal radiographic changes found incidentally, mild anemia, and occasional visual impairment secondary to optic nerve compression. Life expectancy in IAO is usually normal. ADOII. Onset is usually late childhood or adolescence. Findings may include: fractures (in any long bone and/or the posterior arch of a vertebra), scoliosis, hip osteoarthritis, and osteomyelitis of the mandible or septic osteitis or osteoarthritis elsewhere. Cranial nerve compression is rare.</Attribute>
                <XRef ID="NBK1127" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301306</ID>
                <ID Source="BookShelf">NBK1127</ID>
              </Citation>
              <Citation Type="general">
                <ID Source="PubMed">14564431</ID>
              </Citation>
              <XRef ID="53" DB="Orphanet" />
              <XRef ID="C3179239" DB="MedGen" />
              <XRef ID="MONDO:0008156" DB="MONDO" />
              <XRef Type="MIM" ID="166600" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4932697" SubmissionDate="2022-05-21" DateLastUpdated="2022-05-28" DateCreated="2022-05-28">
        <ClinVarSubmissionID localKey="NC_000016.10:g.1447662_1447662delT|OMIM:166600" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV002518715" DateUpdated="2022-05-28" DateCreated="2022-05-28" Type="SCV" Version="1" SubmitterName="Mendelics" OrgID="500035" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-05-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Mendelics Assertion Criteria 2019</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fxi2k7be/mendelics_assertion_criteria_2019.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CLCN7" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000016.10:g.1447662_1447662delT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="166600" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>MENDELICS_CLINVAR_033</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4932697" TraitType="Disease" MappingType="XRef" MappingValue="166600" MappingRef="OMIM">
        <MedGen CUI="C3179239" Name="Autosomal dominant osteopetrosis 2" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

